HBV
Los inhibidores del VHB son compuestos diseñados para atacar e inhibir varias etapas del ciclo de vida del virus de la hepatitis B (VHB). Estos inhibidores pueden interferir con la replicación viral, el ensamblaje o la liberación, reduciendo así la carga viral y ayudando a manejar las infecciones crónicas por VHB. La investigación sobre inhibidores del VHB es crucial para desarrollar terapias antivirales efectivas que prevengan enfermedades hepáticas y cánceres asociados con el VHB. En CymitQuimica, ofrecemos una gama de inhibidores del VHB para apoyar su investigación en virología, desarrollo de medicamentos antivirales y gestión de enfermedades infecciosas.
Se han encontrado 176 productos de "HBV"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Pradefovir
CAS:<p>Pradefovir (Remofovir) is a prodrug for chronic HBV, converting to PMEA in the liver with a Km of 60 μM and clearance of 359 ml/min.</p>Fórmula:C17H19ClN5O4PPureza:97.50%Forma y color:SolidPeso molecular:423.79HBV-IN-8
CAS:<p>HBV-IN-6 is a potent inhibitor of HBV (EC50: 287.9 nM).</p>Fórmula:C21H25ClFN5O5S2Forma y color:SolidPeso molecular:546.04HBF-0259
CAS:HBF-0259 is an inhibitors of hepatitis B virus surface antigen (HBsAg) secretion with an EC50 of 11.3 μM and a CC50 value of >50 μM in HepG2.2.15 cells.Fórmula:C16H12Cl2FN5Pureza:98.07% - 99.42%Forma y color:SolidPeso molecular:364.2HBV-IN-13
CAS:<p>HBV-IN-12 is a potent inhibitor of hepatitis B surface antigen (HBsAg).</p>Fórmula:C22H25NO7Forma y color:SolidPeso molecular:415.44HEC72702
CAS:<p>HEC72702: New HBV capsid inhibitor, from GLS4. No CYP1A2, CYP3A4, CYP2B6 induction at 10μM.</p>Fórmula:C24H26BrFN4O5SForma y color:SolidPeso molecular:581.45HBV-IN-17
CAS:<p>HBV-IN-17 (compound 8) is a potent regulator of HBV capsid assembly (EC50: 511 nM).</p>Fórmula:C17H15F6N5O2Forma y color:SolidPeso molecular:435.32Oxynitidine
CAS:<p>Oxynitidine, an HBV inhibitor (ID50 = 30.8 µg/mL), effectively suppresses HBV DNA replication and may be utilized in viral infection research [1].</p>Fórmula:C21H17NO5Pureza:98%Forma y color:SolidPeso molecular:363.36HBV-IN-41
CAS:<p>HBV-IN-41 (compound 45) is a potent, orally active inhibitor of Hepatitis B Virus (HBV), exhibiting an EC50 value of 0.027μM [1].</p>Fórmula:C18H19ClFN5O3Pureza:98%Forma y color:SolidPeso molecular:407.83Emtricitabine triphosphate tetrasodium salt
CAS:<p>Emtricitabine triphosphate tetrasodium salt is the tetrasodium salt form of the phosphorylated anabolite (-)-Emtricitabine triphosphate, an active nucleoside</p>Fórmula:C8H9FN3Na4O12P3SPureza:98%Forma y color:SolidPeso molecular:575.11Tobevibart
CAS:<p>Tobevibart, an IgG1-lambda humanized monoclonal antibody targeting the hepatitis B virus (HBV) surface envelope protein, exhibits antiviral activity [1].</p>Pureza:98%Forma y color:LiquidIR415
CAS:<p>IR415 selectively interacts with Hepatitis B virus X protein (HBx, Kd = 2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBx</p>Fórmula:C13H14F2N4SPureza:99.85%Forma y color:SolidPeso molecular:296.34Valtorcitabine dihydrochloride
CAS:<p>Valtorcitabine dihydrochloride, a DNA polymerase inhibitor, is used potentially for the treatment of HBV infection.</p>Fórmula:C14H24Cl2N4O5Forma y color:SolidPeso molecular:399.27Besifovir Dipivoxil maleate
CAS:<p>Besifovir Dipivoxil maleate, an oral HBV prodrug (LB80380), suppresses HBV DNA in naive and lamivudine-resistant CHB cases.</p>Fórmula:C22H34N5O8PPureza:98%Forma y color:SolidPeso molecular:527.51HBV-IN-30
CAS:<p>HBV-IN-30, a flavone derivative, inhibits cccDNA in HBV research.</p>Fórmula:C22H18BrClO6Forma y color:SolidPeso molecular:493.73SHR5133
CAS:<p>SHR5133 is a potent, orally active regulator of HBV capsid assembly that reduces HBV DNA (EC50: 26.6 nM).</p>Fórmula:C19H18F4N6O2Forma y color:SolidPeso molecular:438.38AB-836
CAS:<p>AB-836, an orally active hepatitis B virus (HBV) capsid inhibitor, hampers viral replication by engaging with the HBV core protein.</p>Fórmula:C20H15F3N4O2Forma y color:SolidPeso molecular:400.35Lagociclovir valactate
CAS:<p>Lagociclovir valactate is a prodrug of Lagociclovir . Lagociclovir valactate is an orally active anti- HBV agent [1] .</p>Fórmula:C18H25FN6O6Forma y color:SolidPeso molecular:440.43Linvencorvir
CAS:<p>Linvencorvir is a hepatitis B virus (HBV) core protein variant modifier used to treat chronic HBV infection.</p>Fórmula:C29H35FN6O5SPureza:99.9% - 99.9%Forma y color:SolidPeso molecular:598.69Tenofovir amibufenamide
CAS:<p>Tenofovir amibufenamide (HS-10234) 是一种 Tenofovir 前药，是一种具有口服活性的抗病毒化合物。Tenofovir amibufenamide 对乙型肝炎病毒 (HBV)具有抑制作用，可用于慢性乙型肝炎 (CHB) 研究。</p>Fórmula:C22H31N6O5PPureza:99.19% - 99.87%Forma y color:SolidPeso molecular:490.49HBV-IN-24
<p>HBV-IN-24 inhibits HBV DNA, HBsAg, HBeAg (EC50: 0.6, 0.6, 4.6 nM), and has antiviral properties with neurotoxicity mitigation.</p>Fórmula:C23H27NO6Forma y color:SolidPeso molecular:413.46
